Page last updated: 2024-08-24

triazoles and Fatty Liver

triazoles has been researched along with Fatty Liver in 29 studies

Research

Studies (29)

TimeframeStudies, this research(%)All Research%
pre-19901 (3.45)18.7374
1990's1 (3.45)18.2507
2000's4 (13.79)29.6817
2010's22 (75.86)24.3611
2020's1 (3.45)2.80

Authors

AuthorsStudies
Braeuning, A; Lasch, A; Lichtenstein, D; Marx-Stoelting, P1
Hong, N; Kim, SI; Park, S; Rhee, Y; Seo, DH; Sohn, JH; Yoon, HG1
Braeuning, A; de Sousa, G; Durinck, S; Katsanou, ES; Konstantinidou, P; Lampen, A; Luckert, C; Machera, K; Milani, ES; Peijnenburg, AACM; Rahmani, R; Rajkovic, A; Rijkers, D; Spyropoulou, A; Stamou, M; Stoopen, G; Sturla, S; Wollscheid, B; Zucchini-Pascal, N1
Fukui, K; Nangaku, M; Saito, H; Sugahara, M; Tanaka, S; Tanaka, T; Wakashima, T1
Braeuning, A; Buhrke, T; Knebel, C; Lampen, A; Marx-Stoelting, P; Süssmuth, R1
Akaslan, SB; Arslan, M; Cakir, N; Degertekin, CK; Toruner, FB; Yilmaz, G1
Degli Antoni, A; Ferrari, C; Fragola, V; Manfredi, R; Weimer, LE1
Anand, S; Bhatia, T; Olaywi, M; Singhal, S1
Chew, GT; Sahebkar, A; Watts, GF1
Aguilera-Lizarraga, J; Blanco, JR; Narro, J; Ochoa-Callejero, L; Oteo, JA; Pérez-Martínez, L; Pérez-Matute, P; Recio, E; Rubio-Mediavilla, S1
Choi, YK; Jang, BK; Jung, GS; Jung, YA; Kim, HS; Kim, JG; Kim, MK; Lee, IK; Park, KG; Seo, HY1
Chen, D; Deng, Y; Feng, G; He, P; Hu, R; Huang, T; Li, E; Li, L; Li, Y; Liang, Z; Lin, Y; Liu, J; Lu, Y; Ma, R; Su, F; Sun, S; Tong, Z; Wang, S; Wang, X; Wu, Y; Xu, Z; Zhang, H; Zhang, X; Zhang, Y; Zhao, Y1
Hashizume, H; Horiguchi, N; Kakizaki, S; Kusano, M; Mori, M; Ohyama, T; Sato, K; Yamada, M; Yamazaki, Y1
Bugeon, L; Cheung, J; Dallman, MJ; Lamb, JR; Marchesi, JR; McBrien, M; Progatzky, F; Sangha, NJ; Scott, J; Shia, A; Yoshida, N1
Evans, A; Lacey, R1
Aroor, AR; Dunham, MM; Ford, DA; Ford, KD; Habibi, J; Lastra, G; Manrique, C; Nistala, R; Parks, EJ; Rector, RS; Sowers, JR; Thyfault, JP1
Hamada, H; Ishigure, T; Kakutani, M; Kume, S; Nishiu, J; Ohta, T; Okuma, C; Sakata, S; Sano, R; Tadaki, H; Taniuchi, H1
Berger, JP; Berthiaume, M; Deshaies, Y; Festuccia, WT; Laplante, M; Thieringer, R1
Fu, N; Li, LX; Liang, BL; Nan, YM; Wang, RQ; Wu, WJ; Yu, J; Zhao, JM; Zhao, SX1
Cross, LB; Foard, J; Gross, BN; Wood, Y1
Borelli, MI; Del Zotto, H; Flores, LE; Francini, F; Gagliardino, JJ; Madrid, VG; Maiztegui, B; Massa, ML; Raschia, MA; Rebolledo, OR1
Aihara, Y; Fukui, H; Ikenaka, Y; Kaji, K; Kawaratani, H; Kitade, M; Namisaki, T; Noguchi, R; Shirai, Y; Tsujimoto, T; Yanase, K; Yoshii, J; Yoshiji, H1
Celikel, CA; Deyneli, O; Duman, DG; Kalayci, C; Yilmaz, Y; Yonal, O1
Isogawa, A; Iwamoto, M; Koike, K; Ohki, T; Ohsugi, M; Omata, M; Tagawa, K; Toda, N; Yoshida, H1
Chen, M; Li, J; Sun, L; Wang, C; Zuo, Z1
Currie, RA; Milburn, G; Moggs, JG; Pastoor, T; Peffer, RC; Rusyn, I; Waechter, F; Wright, J1
Bellmann, R; Bellmann-Weiler, R; Graziadei, I; Joannidis, M; Vogel, W; Weiler, S; Zoller, H1
Morii, S; Nakao, I; Nishimura, R; Shikata, N; Tsubura, A1
Ishii, H; Ninobe, S; Suga, T1

Reviews

2 review(s) available for triazoles and Fatty Liver

ArticleYear
Novel anti-diabetic agents in non-alcoholic fatty liver disease: a mini-review.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2013, Volume: 12, Issue:6

    Topics: Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Fatty Liver; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Liraglutide; Liver; Non-alcoholic Fatty Liver Disease; Peptides; Pyrazines; Sitagliptin Phosphate; Transaminases; Treatment Outcome; Triazoles; Venoms

2013
New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease.
    Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:4

    Topics: Acetates; Animals; Atherosclerosis; Chalcones; Cholesterol, HDL; Dyslipidemias; Fatty Liver; Fenofibrate; Humans; Insulin Resistance; Lipoproteins, HDL; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptors; Propionates; Quinolines; Sulfonamides; Thiazoles; Triazoles; Triglycerides

2014

Trials

1 trial(s) available for triazoles and Fatty Liver

ArticleYear
A prospective, randomized study on hepatotoxicity of anastrozole compared with tamoxifen in women with breast cancer.
    Cancer science, 2014, Volume: 105, Issue:9

    Topics: Aged; Anastrozole; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Fatty Liver; Female; Humans; Liver; Middle Aged; Nitriles; Prospective Studies; Tamoxifen; Treatment Failure; Triazoles

2014

Other Studies

26 other study(ies) available for triazoles and Fatty Liver

ArticleYear
More than additive effects on liver triglyceride accumulation by combinations of steatotic and non-steatotic pesticides in HepaRG cells.
    Archives of toxicology, 2021, Volume: 95, Issue:4

    Topics: Adverse Outcome Pathways; Carcinoma, Hepatocellular; Cell Line, Tumor; Dioxolanes; Dioxoles; Fatty Acids; Fatty Liver; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Models, Theoretical; Pesticides; Pyrroles; Triazoles; Triglycerides

2021
Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study.
    European journal of cancer (Oxford, England : 1990), 2017, Volume: 82

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers; Breast Neoplasms; Chemotherapy, Adjuvant; Fatty Liver; Female; Humans; Incidence; Letrozole; Lipids; Middle Aged; Nitriles; Propensity Score; Retrospective Studies; Tamoxifen; Triazoles

2017
Adverse Outcome Pathway-Driven Analysis of Liver Steatosis in Vitro: A Case Study with Cyproconazole.
    Chemical research in toxicology, 2018, 08-20, Volume: 31, Issue:8

    Topics: Adverse Outcome Pathways; Biological Assay; Cell Line, Tumor; Dose-Response Relationship, Drug; Fatty Liver; Fungicides, Industrial; Gene Expression; HEK293 Cells; Hepatocytes; Humans; Mitochondria, Liver; Models, Biological; Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear; Risk Assessment; Triazoles; Triglycerides

2018
Inhibition of prolyl hydroxylase domain (PHD) by JTZ-951 reduces obesity-related diseases in the liver, white adipose tissue, and kidney in mice with a high-fat diet.
    Laboratory investigation; a journal of technical methods and pathology, 2019, Volume: 99, Issue:8

    Topics: Adipose Tissue, White; Animals; Body Weight; Diet, High-Fat; Fatty Liver; Kidney; Liver; Male; Mice; Mice, Inbred C57BL; N-substituted Glycines; Obesity; Prolyl Hydroxylases; Pyridines; Triazoles

2019
Pregnane X receptor mediates steatotic effects of propiconazole and tebuconazole in human liver cell lines.
    Archives of toxicology, 2019, Volume: 93, Issue:5

    Topics: Carcinoma, Hepatocellular; Cell Line; Fatty Liver; Fungicides, Industrial; Gene Knockout Techniques; Hep G2 Cells; Humans; Liver Neoplasms; Pregnane X Receptor; Triazoles

2019
Effects of sitagliptin on nonalcoholic fatty liver disease in diet-induced obese rats.
    Metabolic syndrome and related disorders, 2013, Volume: 11, Issue:4

    Topics: Alanine Transaminase; Animals; Blood Glucose; Cholesterol; Diet, High-Fat; Dipeptidyl-Peptidase IV Inhibitors; Fatty Liver; Female; Insulin; Insulin Resistance; Liver; Non-alcoholic Fatty Liver Disease; Obesity; Pyrazines; Rats; Rats, Sprague-Dawley; Sitagliptin Phosphate; Triazoles; Triglycerides

2013
A reduced grade of liver fibro-steatosis after raltegravir, maraviroc and fosamprenavir in an HIV/HCV co-infected patient with chronic hepatitis, cardiomyopathy, intolerance to nelfinavir and a marked increase of serum creatine phosphokinase levels probab
    The West Indian medical journal, 2012, Volume: 61, Issue:9

    Topics: Adult; Carbamates; Cardiomyopathies; Chemical and Drug Induced Liver Injury; Creatine Kinase; Cyclohexanes; Drug Substitution; Drug Therapy, Combination; Fatty Liver; Furans; Hepatitis C, Chronic; HIV Fusion Inhibitors; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; Humans; Liver Cirrhosis; Male; Maraviroc; Organophosphates; Pyrrolidinones; Raltegravir Potassium; Sulfonamides; Triazoles

2012
Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD).
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:7

    Topics: Animals; Cyclohexanes; Disease Models, Animal; Fatty Liver; Histocytochemistry; Liver; Liver Function Tests; Male; Maraviroc; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Triazoles

2014
Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis.
    Diabetes research and clinical practice, 2014, Volume: 105, Issue:1

    Topics: Animals; Biomarkers; Blotting, Western; Choline Deficiency; Diet; Dipeptidyl-Peptidase IV Inhibitors; Endoplasmic Reticulum Stress; Fatty Liver; Immunoenzyme Techniques; Inflammation; Lipid Peroxidation; Liver Cirrhosis; Male; Methionine; Mice; Mice, Inbred C57BL; NF-kappa B; Pyrazines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Sitagliptin Phosphate; Triazoles; Triglycerides

2014
MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis in ob/ob mice.
    World journal of gastroenterology, 2014, Nov-21, Volume: 20, Issue:43

    Topics: Adiponectin; AMP-Activated Protein Kinases; Animals; Biomarkers; Cytoprotection; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Fatty Liver; Gene Expression Regulation; Lipogenesis; Liver; Male; Mice, Obese; Obesity; Signal Transduction; Time Factors; Triazoles; Triglycerides

2014
Dietary cholesterol directly induces acute inflammasome-dependent intestinal inflammation.
    Nature communications, 2014, Dec-23, Volume: 5

    Topics: Animals; Benzoxazoles; Carrier Proteins; Caspase 1; Cholesterol, Dietary; Diet, High-Fat; Fatty Acids; Fatty Liver; Female; Immunity, Innate; Inflammasomes; Inflammation; Interleukin-1beta; Intestinal Mucosa; Intestines; Membrane Transport Proteins; Mice; Mice, Inbred BALB C; Myeloid Cells; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Triazoles; Zebrafish

2014
An unusual cause of jaundice in a patient with breast cancer.
    BMJ case reports, 2014, Dec-24, Volume: 2014

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Biopsy; Breast Neoplasms; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Fatty Liver; Female; Humans; Jaundice; Liver; Liver Function Tests; Middle Aged; Nitriles; Triazoles

2014
Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function.
    Diabetes, 2015, Volume: 64, Issue:6

    Topics: Animals; Blotting, Western; Body Composition; Ceramides; Diet, Western; Dipeptidyl-Peptidase IV Inhibitors; Fatty Liver; Insulin Resistance; Liver; Mice; Mice, Inbred C57BL; Mitochondria; Palmitates; Pyruvic Acid; Triazoles; Triglycerides

2015
JTP-103237, a monoacylglycerol acyltransferase inhibitor, prevents fatty liver and suppresses both triglyceride synthesis and de novo lipogenesis.
    Journal of pharmacological sciences, 2015, Volume: 128, Issue:3

    Topics: Acyltransferases; Animals; Antigens, Bacterial; Bacterial Proteins; Diglycerides; Disease Models, Animal; Enzyme Inhibitors; Fatty Acids; Fatty Liver; Gene Expression; Intestinal Absorption; Lipogenesis; Liver; Male; Mice, Inbred C57BL; Piperazines; Sterol Regulatory Element Binding Protein 1; Triazoles; Triglycerides

2015
Additive action of 11beta-HSD1 inhibition and PPAR-gamma agonism on hepatic steatosis and triglyceridemia in diet-induced obese rats.
    International journal of obesity (2005), 2009, Volume: 33, Issue:5

    Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adiponectin; Animals; Disease Models, Animal; Fatty Liver; Male; Obesity; PPAR gamma; Rats; Rats, Sprague-Dawley; Receptors, Adiponectin; Rosiglitazone; Thiazolidinediones; Triazoles; Triglycerides

2009
Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice.
    Scandinavian journal of gastroenterology, 2009, Volume: 44, Issue:9

    Topics: Alanine Transaminase; Analysis of Variance; Animals; Antioxidants; Apoptosis; Aspartate Aminotransferases; bcl-2-Associated X Protein; Blotting, Western; Cyclooxygenase 2; Fatty Liver; Genes, bcl-2; Inflammation; Lipid Peroxidation; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; NF-kappa B p50 Subunit; Oxidative Stress; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta1; Triazoles; Vitamin E

2009
Elevated hepatic enzymes potentially associated with sitagliptin.
    The Annals of pharmacotherapy, 2010, Volume: 44, Issue:2

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Fatty Liver; Humans; Liver; Liver Function Tests; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Triazoles

2010
Sitagliptin prevents the development of metabolic and hormonal disturbances, increased β-cell apoptosis and liver steatosis induced by a fructose-rich diet in normal rats.
    Clinical science (London, England : 1979), 2011, Volume: 120, Issue:2

    Topics: Animals; Apoptosis; Blood Glucose; Body Weight; Diet; Dipeptidyl-Peptidase IV Inhibitors; Drinking; Drug Evaluation, Preclinical; Eating; Exenatide; Fatty Liver; Fructose; Glucose Tolerance Test; Hypoglycemic Agents; Insulin-Secreting Cells; Male; Metabolic Syndrome; Peptides; Pyrazines; Rats; Rats, Wistar; Sitagliptin Phosphate; Triazoles; Venoms

2011
Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats.
    American journal of physiology. Gastrointestinal and liver physiology, 2011, Volume: 300, Issue:6

    Topics: Administration, Oral; Angiogenesis Inhibitors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzoates; Carcinoma, Hepatocellular; Cell Proliferation; Cells, Cultured; Choline Deficiency; Deferasirox; Disease Progression; Drug Therapy, Combination; Fatty Liver; Hepatic Stellate Cells; Iron Chelating Agents; Liver Cirrhosis, Experimental; Liver Neoplasms, Experimental; Losartan; Male; Neovascularization, Pathologic; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats; Rats, Inbred F344; Time Factors; Transforming Growth Factor beta1; Triazoles

2011
Effects of sitagliptin in diabetic patients with nonalcoholic steatohepatitis.
    Acta gastro-enterologica Belgica, 2012, Volume: 75, Issue:2

    Topics: Adult; Body Mass Index; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Fatty Liver; Female; Hepatocytes; Humans; Male; Middle Aged; Pilot Projects; Pyrazines; Sitagliptin Phosphate; Triazoles

2012
The effectiveness of liraglutide in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus compared to sitagliptin and pioglitazone.
    TheScientificWorldJournal, 2012, Volume: 2012

    Topics: Adult; Alanine Transaminase; Blood Glucose; Body Weight; Comorbidity; Diabetes Mellitus, Type 2; Drug Evaluation; Drug Therapy, Combination; Fatty Liver; Female; Follow-Up Studies; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Inflammation; Liraglutide; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Multivariate Analysis; Non-alcoholic Fatty Liver Disease; Odds Ratio; Pioglitazone; Platelet Count; Pyrazines; Retrospective Studies; Sitagliptin Phosphate; Thiazolidinediones; Treatment Outcome; Triazoles

2012
Chronic exposure to paclobutrazol causes hepatic steatosis in male rockfish Sebastiscus marmoratus and the mechanism involved.
    Aquatic toxicology (Amsterdam, Netherlands), 2013, Jan-15, Volume: 126

    Topics: Animals; Fatty Liver; Fishes; Gene Expression Profiling; Gene Expression Regulation; Lipids; Liver; Triazoles; Water Pollutants, Chemical

2013
Mouse liver effects of cyproconazole, a triazole fungicide: role of the constitutive androstane receptor.
    Toxicological sciences : an official journal of the Society of Toxicology, 2007, Volume: 99, Issue:1

    Topics: Administration, Oral; Animals; Antigens, Differentiation; Aryl Hydrocarbon Hydroxylases; Cell Proliferation; Cytochrome P450 Family 2; Diet; Dose-Response Relationship, Drug; Enzyme Induction; Fatty Liver; Fungicides, Industrial; Gene Expression Regulation; Gene Silencing; Hepatocytes; Hypertrophy; Liver; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Organ Size; Phenobarbital; Proto-Oncogene Proteins c-mdm2; Receptors, Androgen; Species Specificity; Steroid Hydroxylases; Triazoles; Vacuoles

2007
Altered pharmacokinetics of voriconazole in a patient with liver cirrhosis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Antifungal Agents; Fatty Liver; Humans; Liver Cirrhosis; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2007
Improved lipid visualization with a modified osmium tetroxide method using ultrasonic treatment and intensification with imidazole or triazole.
    Biotechnic & histochemistry : official publication of the Biological Stain Commission, 1995, Volume: 70, Issue:1

    Topics: Fatty Liver; Histocytochemistry; Humans; Imidazoles; Lipids; Liver; Osmium Tetroxide; Proteolipids; Staining and Labeling; Tissue Fixation; Triazoles; Ultrasonics

1995
Effect of 3-amino-1,2,4-triazole treatment on catalase activity and triglyceride level in fatty liver of the rat.
    Biochemical pharmacology, 1977, Apr-01, Volume: 26, Issue:7

    Topics: Amitrole; Animals; Carbon Tetrachloride Poisoning; Catalase; Ethanol; Ethionine; Fatty Liver; Female; Male; Rats; Triazoles; Triglycerides

1977